fluconazole has been researched along with Abdominal Abscess in 9 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Abdominal Abscess: An abscess located in the abdominal cavity, i.e., the cavity between the diaphragm above and the pelvis below. (From Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Fifteen months after the discontinuation of immunosuppressive therapy, Eschericia coli peritonitis developed, which was treated with ceftazidime intraperitoneally; he received fluconazole as prophylactic antifungal therapy during this period." | 7.72 | Successful treatment of mucormycosis peritonitis with liposomal amphotericin B in a patient on long-term peritoneal dialysis. ( Dosekun, AK; Serna, JH; Wanger, A, 2003) |
| " Fifteen months after the discontinuation of immunosuppressive therapy, Eschericia coli peritonitis developed, which was treated with ceftazidime intraperitoneally; he received fluconazole as prophylactic antifungal therapy during this period." | 3.72 | Successful treatment of mucormycosis peritonitis with liposomal amphotericin B in a patient on long-term peritoneal dialysis. ( Dosekun, AK; Serna, JH; Wanger, A, 2003) |
| "For optimal treatment, abdominal abscesses require prompt drainage and properly selected antibiotics at adequate doses." | 1.37 | Impact of evaluating antibiotic concentrations in abdominal abscesses percutaneously drained. ( Barshikar, S; Baylor, AE; Dolman, HS; Glowniak, J; Hong, K; Lavery, T; Nailor, M; Singla, R; Stassinopoulus, J; Tyburski, JG; Wilson, RF; Zimmerman, LH, 2011) |
| "A 47-year-old man with diabetic nephropathy and alcoholic liver disease developed disseminated candidiasis, with the initial presentation of pyomyositis." | 1.33 | Pyomyositis with hepatic and perinephric abscesses caused by Candida albicans in a diabetic nephropathy patient. ( Peng, YJ; Tsai, SH; Wang, NC, 2006) |
| "Amphotericin B treatment was significantly more effective than fluconazole treatment (3." | 1.32 | Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor. ( Kullberg, BJ; Netea, MG; van der Meer, JW; van Krieken, JH; Verweij, PE; Vonk, AG, 2003) |
| "Fluconazole was effective with both administration methods." | 1.31 | Effects of fluconazole on viable cell count in experimental intraperitoneal Candida abscesses. ( Hayasaki, Y; Hua, YX; Mikamo, H; Sato, Y; Tamaya, T, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Schattner, A | 1 |
| Finn, T | 1 |
| Glick, Y | 1 |
| Okmen, F | 1 |
| Ekici, H | 1 |
| Ari, SA | 1 |
| Zimmerman, LH | 1 |
| Tyburski, JG | 1 |
| Glowniak, J | 1 |
| Singla, R | 1 |
| Lavery, T | 1 |
| Nailor, M | 1 |
| Stassinopoulus, J | 1 |
| Hong, K | 1 |
| Barshikar, S | 1 |
| Dolman, HS | 1 |
| Baylor, AE | 1 |
| Wilson, RF | 1 |
| Islam, S | 1 |
| Zaidi, AK | 1 |
| Wilson, J | 1 |
| Serna, JH | 1 |
| Wanger, A | 1 |
| Dosekun, AK | 1 |
| Vonk, AG | 1 |
| Netea, MG | 1 |
| van Krieken, JH | 1 |
| Verweij, PE | 1 |
| van der Meer, JW | 1 |
| Kullberg, BJ | 1 |
| Tsai, SH | 1 |
| Peng, YJ | 1 |
| Wang, NC | 1 |
| Alkhatib, A | 1 |
| Kawji, AS | 1 |
| Adler, DG | 1 |
| Mikamo, H | 1 |
| Hua, YX | 1 |
| Hayasaki, Y | 1 |
| Sato, Y | 1 |
| Tamaya, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Antibiotic Irrigations for Intra-Abdominal Drains[NCT03476941] | Phase 2 | 50 participants (Anticipated) | Interventional | 2019-04-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 other studies available for fluconazole and Abdominal Abscess
| Article | Year |
|---|---|
Not What It Seems: Obstructive Jaundice in an HIV-Positive Patient.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Invasive; Diagnosis, Diffe | 2021 |
Case Report of a Tubo-ovarian Abscess Caused by Candida kefyr.
Topics: Abdominal Abscess; Abdominal Pain; Adult; Antifungal Agents; Candida; Candidiasis; Cystectomy; Fallo | 2018 |
Impact of evaluating antibiotic concentrations in abdominal abscesses percutaneously drained.
Topics: Abdominal Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofl | 2011 |
Peritoneal infection with multiple species of Candida: a case report.
Topics: Abdominal Abscess; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida tropicalis; | 2002 |
Successful treatment of mucormycosis peritonitis with liposomal amphotericin B in a patient on long-term peritoneal dialysis.
Topics: Abdominal Abscess; Amphotericin B; Antifungal Agents; Bacteroides fragilis; Combined Modality Therap | 2003 |
Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor.
Topics: Abdominal Abscess; Adjuvants, Immunologic; Amphotericin B; Animals; Antifungal Agents; Candida albic | 2003 |
Pyomyositis with hepatic and perinephric abscesses caused by Candida albicans in a diabetic nephropathy patient.
Topics: Abdominal Abscess; Antifungal Agents; Candida albicans; Candidiasis; Diabetic Nephropathies; Diagnos | 2006 |
First reported case of a Candida glabrata perihepatic abscess as a complication of percutaneous endoscopic gastrostomy tube placement.
Topics: Abdominal Abscess; Antifungal Agents; Candida glabrata; Candidiasis; Female; Fluconazole; Gastrostom | 2007 |
Effects of fluconazole on viable cell count in experimental intraperitoneal Candida abscesses.
Topics: Abdominal Abscess; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Fluconazole; Mi | 2000 |